Sato Clear (Sato Pharmaceutical Co., Ltd.)


Welcome to the PulseAid listing for the Sato Clear drug offered from Sato Pharmaceutical Co., Ltd.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sato Pharmaceutical Co., Ltd.
NON-PROPRIETARY NAME: NAPHAZOLINE HYDROCHLORIDE
SUBSTANCE NAME: NAPHAZOLINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 1989-05-31
END MARKETING DATE: 0000-00-00


Sato Clear HUMAN OTC DRUG Details:

Item DescriptionSato Clear from Sato Pharmaceutical Co., Ltd.
LABELER NAME: Sato Pharmaceutical Co., Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 12(mg/100mL)
START MARKETING DATE: 1989-05-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49873-044_d6810599-b9b2-486b-bba1-a2a77ada3636
PRODUCT NDC: 49873-044
APPLICATION NUMBER: part349

Other NAPHAZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Naphazoline
Insight PharmaceuticalsPrivine
Insight Pharmaceuticals LLCPrivine
International Nature NutraceuticalsPi Yen Chin
Preferred Pharmaceuticals, Inc.AK-Con
Proficient Rx LPNaphazoline
Rebel Distributors Corp.AK-Con
Sato Pharmaceutical Co., Ltd.Sato Clear